19 States Mapped With Remdesivir Manufacturers For Faster Supply

Remdesivir being an investigational therapy drug is given in acute and severe versions of Covid where oxygen support is a must

The centre has mapped manufacturers of the anti-viral drug remdesivir with 19 states that have high Covid case burden. This will ensure smooth and fast delivery of the medicine, the centre said in a statement. "Keeping in mind the sudden surge in demand in the country for remdesivir injection required for COVID-19 therapy, the manufacturing capacity of domestic remdesivir manufacturers has been ramped up," the centre said. "All support is being extended to manufacturers by the government in this endeavour. The production capacity is being ramped up from current level of 38 lakh vials per month to 74 lakh vials per month, and 20 additional manufacturing sites have been approved. Export of remdesivir has also been prohibited in order to shore up domestic supplies," it said. The Health Ministry and the Department of Pharmaceuticals have made an interim allocation of remdesivir for 19 states and Union Territories up to April 30.